Literature DB >> 28013263

Invasive Systemic Infection After Hospital Treatment for Diabetic Foot Ulcer: Risk of Occurrence and Effect on Survival.

Shey-Ying Chen1,2, John M Giurini3, Adolf W Karchmer4.   

Abstract

BACKGROUND: Diabetic foot ulcers (DFUs) threaten limbs and prompt hospitalization. After hospitalization, remote-site invasive systemic infection related to DFU (DFU-ISI) may occur. The characteristics of DFU-ISIs and their effect on mortality risk have not been defined.
METHODS: We conducted a retrospective cohort study of 819 diabetic patients hospitalized for treatment of 1212 unique DFUs during a 9-year period. We defined the index ulcer as that present at the first (index) DFU admission to our hospital. We defined DFU-ISI as a nonfoot infection that occurred after the index hospitalization and was caused by a microorganism concomitantly or previously cultured from the index ulcer. We determined the frequency, risk factors, and mortality risk associated with DFU-ISIs.
RESULTS: After 1212 index DFU hospitalizations, 141 patients had 172 DFU-ISIs. Of the initial 141 DFU-ISIs, 64% were bacteremia, 13% deep abscesses, 10% pneumonia, 7% endocarditis, and 6% skeletal infections. Methicillin-resistant Staphylococcus aureus (MRSA) caused 57% of the ISIs. Patients with initial DFU cultures yielding MRSA and protracted open ulcers had a high 24-month cumulative probability of DFU-ISI (31%) and all-cause mortality rate (13%). Analysis with Cox regression modeling showed that complicated ulcer healing (hazard ratio, 3.812; 95% confidence interval, 2.434-5.971) and initial DFU culture yielding MRSA (2.030; 1.452-2.838) predicted DFU-ISIs and that DFU-ISIs were associated with increased mortality risk (1.987; 1.106-3.568).
CONCLUSIONS: DFU-ISIs are important late complications of DFUs. Prevention of DFU-ISIs should be studied prospectively. Meanwhile, clinicians should aggressively incorporate treatment to accelerate ulcer healing and address MRSA into the care of diabetic patients with foot ulcers.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  diabetes mellitus; foot ulcer; methicillin resistant Staphylococcus aureuszzm321990; mortality.; systemic infection

Mesh:

Year:  2016        PMID: 28013263     DOI: 10.1093/cid/ciw736

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

Review 1.  Skin and sepsis: contribution of dermatology to a rapid diagnosis.

Authors:  A Pulido-Pérez; E Bouza; M Bergón-Sendín; R Suárez-Fernández; P Muñoz-Martín
Journal:  Infection       Date:  2021-04-15       Impact factor: 3.553

2.  Association Between Diabetic Foot Infection Wound Culture Positivity and 1-Year Admission for Invasive Infection: A Multicenter Cohort Study.

Authors:  Westyn Branch-Elliman; Daniel Sturgeon; Adolf W Karchmer; Hillary J Mull
Journal:  Open Forum Infect Dis       Date:  2021-04-02       Impact factor: 4.423

3.  MXenes-integrated microneedle combined with asiaticoside to penetrate the cuticle for treatment of diabetic foot ulcer.

Authors:  Pei Wang; Yun Wang; Yang Yi; Yan Gong; Haoran Ji; Yuci Gan; Fei Xie; Jinchen Fan; Xiansong Wang
Journal:  J Nanobiotechnology       Date:  2022-06-07       Impact factor: 9.429

4.  Effects of adding adjunctive hyperbaric oxygen therapy to standard wound care for diabetic foot ulcers: a protocol for a systematic review with meta-analysis and trial sequential analysis.

Authors:  Julie Vinkel; Niels Frederich Rose Holm; Janus C Jakobsen; Ole Hyldegaard
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

5.  Prevalence and associated factors of diabetic foot ulcers among type 2 diabetic patients attending chronic follow-up clinics at governmental hospitals of Harari Region, Eastern Ethiopia: A 5-year (2013-2017) retrospective study.

Authors:  Assefa Tola; Lemma Demissie Regassa; Yohanes Ayele
Journal:  SAGE Open Med       Date:  2021-01-20

6.  Engineering diabetic human skin equivalent for in vitro and in vivo applications.

Authors:  Atieh Abedin-Do; Ze Zhang; Yvan Douville; Mirelle Méthot; Julien Bernatchez; Mahmoud Rouabhia
Journal:  Front Bioeng Biotechnol       Date:  2022-09-30

7.  Decreased accuracy of erythrocyte sedimentation rate in diagnosing osteomyelitis in diabetic foot infection patients with severe renal impairment: A retrospective cross-sectional study.

Authors:  Xin Chen; Yiting Shen; Yuying Wang; Yang Li; Shuyu Guo; Yue Liang; Xuanyu Wang; Siyuan Zhou; Xiaojie Hu; Kaiwen Ma; Rui Tian; Wenting Fei; Yuqin Sheng; Hengjie Cao; Huafa Que
Journal:  PLoS One       Date:  2022-03-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.